On Wednesday, Elon Musk tweeted out that Tesla will be making mobile molecule printers to aid CureVac in creating a vaccine for COVID-19.

A twitter user asked Musk what he thought about the RNA vaccine approach. Elon responded that he thinks synthetic RNA and DNA has amazing potential and that by using these processes it would make solutions to diseases a software problem. He then announced that Tesla is building RNA microfactories for CureVac and possibly others.

Tesla, as a side project, is building RNA microfactories for CureVac & possibly others

— Elon Musk (@elonmusk) July 2, 2020

According to Reuters, CureVac was originally from Tuebingen, since then it has been backed by the Bill and Melinda Gates Foundation. CureVac is an unlisted German company that has claimed that they are making portable automated mRNA production units or printers. These printers are designed to be able to be shipped remotely and create potential vaccines and other mRNA therapies by feeding them formulas. If it is found to have a vaccine for COVID-19 that is approved, production sites can produce millions of doses. This is done easily because mRNA molecules are single stranded and they can be produced in a simple process that does not need living cells that are genetically modified.

This is not the first time Tesla has helped the fight against COVID-19. CNN Business reported Elon Musk’s claim that Tesla delivered more than 1,000 ventilators to California hospitals when COVID cases were skyrocketing.

What the public knows about this project is very little, but the project’s impact is much bigger. These micro factories that have the ability to pump out potential vaccines for diseases would make the process of distribution much faster. If Tesla and CureVac were able to accomplish the goal of creating and replicating the vaccine in mass numbers, it would be an amazing accomplishment and it would help bring the world closer to what it used to be before the global pandemic.